Mr. Jaewon Chung is an associate at Shin & Kim, mainly practicing in the areas of overseas investments, mergers and acquisitions (M&A), private equity funds (PEF), corporate governance, corporate restructuring, and other corporate law matters.

M&A & Investments

• IMM PE’s full exit from Genuone Sciences
• Acquisition of controlling interest in TIRA YUTECH by LS Electric and JKL Partners
• Sale of controlling interest and tender offer for Lutronic
• Helios PE's sale of controlling interest in ISC and new share subscription
• Excelsior PE's acquisition of controlling interest in CytoGen and subscription of new shares and convertible bonds
• SKC's spin-off of its PET film business and sale of its stake
• Acquisition of Changsung Softgel by CVC Technologies Inc. in Taiwan
• OCI’s acquisition of controlling interest in Bukwang Pharmaceutical
• Establishment of STAC, a joint venture (JV) between SK Geocentric and Tokuyama in Japan

Corporate restructuring including mergers, spin-offs, and comprehensive share exchanges

• SK Networks’ spin-off of Speedmate business division and Trading business division
• Tender offer and comprehensive share exchange of SK Networks' stake in SK Rent-a-Car
• Spin-off of Kolmar Pharma, and share exchange of grants and merger of Genuone Sciences with Kolmar Pharma
• SK E&S's tender offer for a stake in Pusan City Gas, share exchange of grants and delisting
• SK Telecom's spin-off of TMap Mobility business unit

Bio-healthcare

• Preparation and review of contracts, including collaborative research agreements, license agreements, sales agreements, clinical trial outsourcing agreements, manufacturing consignment agreements, exclusive distribution agreements, and overseas investment agreements for pharmaceutical companies, medical device companies, biotechnology companies, CROs, etc.
• Advice on economic benefits (rebates) and other compliance matters
• Advice on business structure using a management service organization (MSO)
• Advice on large domestic hospitals and genetic testing organizations on the Medical Service Act, the Bioethics Act, the Act on Decisions on Life-sustaining Treatment, etc.